16 March 2017 1 Min Read
Mediclinic’s drop in market value negatively affects Remgro
Remgro reports a 15% decline in intrinsic net asset value for the six months to December, attributed to Mediclinic’s 38.7% drop in market value
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In